Let’s break barriers to fight Covid-19 together

First COVID-19 neutralizing antibody detected

Identification of promising candidate for COVID19 antibody therapy: Yumab GmbH announced it has identified a fully human monoclonal antibody with neutralizing activity against patient-derived coronavirus strain SARSCoV2. This milestone was achieved in collaboration with the CORAT consortium. CORAT, originally initiated by YUMAB founder Prof. Stefan Dübel (University of Braunschweig) and Prof. Gundram Jung (University of Tübingen), is a world-class consortium of academic and industrial partners aligned to combat Covid-19.

More info